BJSM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Journal of Sports Medicine 2006;40(Supplement 1 ):i30-i34; doi:10.1136/bjsm.2006.027532
Copyright © 2006 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, N
Right arrow Articles by Saugy, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, N
Right arrow Articles by Saugy, M

SUPPLEMENT

Erythropoietin and blood doping

N Robinson, S Giraud, C Saudan, N Baume, L Avois, P Mangin, M Saugy

Swiss Laboratory for Doping Analyses, Institute of Legal Medicine, Lausanne, Switzerland

Correspondence to:
Correspondence to:
M Saugy
Swiss Laboratory for Doping Analyses, Institute of Legal Medicine, Lausanne, Switzerland; martial.saugy{at}chuv.ch

Objective and method: To outline the direct and indirect approaches in the fight against blood doping in sports, the different strategies that have been used and are currently being used to fight efficiently against blood doping are presented and discussed.

Results and conclusions: The paper outlines the different approaches and diagnostic tools that some federations have to identify and target sportspeople demonstrating abnormal blood profiles. Originally blood tests were introduced for medical reasons and for limiting misuse of recombinant human erythropoietin (rHuEPO). In this way it became possible to prevent athletes with haematocrit levels well above normal, and potentially dangerous for their health, competing in sport. Today, with nearly a decade of blood testing experience, sports authorities should be familiar with some of the limitations and specially the ability of blood tests performed prior to competitions to fight efficiently against the misuse of rHuEPO, blood transfusion, and artificial haemoglobin.


Abbreviations: BFU-E, burst forming unit-erythroid; CFU-E, colony forming unit-erythroid; EPO, erythropoietin; IOC, International Olympic Committee; LAD, Swiss Laboratory for Doping Analyses; rHuEPO, recombinant human EPO; sTFR, soluble transferring receptor

Keywords: EPO; doping; transfusion; haematocrit; reticulocyte count




This article has been cited by other articles:


Home page
Br. J. Sports. Med.Home page
P Tscholl, A Junge, and J Dvorak
The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006
Br. J. Sports Med., September 1, 2008; 42(9): 725 - 730.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine